Drug information for NYDRAZID

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 100MG/ML Discontinued   ISONIAZID Isoniazid SANDOZ 8662
TABLET; ORAL 100MG Discontinued   ISONIAZID Isoniazid BRISTOL MYERS SQUIBB 8392

Drug Adverse Effects information for NYDRAZID

Role code Indications Reaction # Reports
C COLITIS ULCERATIVE BLOOD POTASSIUM DECREASED 4
C COLITIS ULCERATIVE BLOOD POTASSIUM INCREASED 4
C COLITIS ULCERATIVE BLOOD SODIUM DECREASED 4
C COLITIS ULCERATIVE BLOOD SODIUM INCREASED 4
C COLITIS ULCERATIVE BRONCHITIS 4
C COLITIS ULCERATIVE BRONCHOPNEUMONIA 4
C COLITIS ULCERATIVE CANDIDA TEST POSITIVE 4
C COLITIS ULCERATIVE CARDIOMEGALY 4
C COLITIS ULCERATIVE CELL DEATH 4
C COLITIS ULCERATIVE DISSEMINATED TUBERCULOSIS 4
C COLITIS ULCERATIVE HAEMATOCRIT DECREASED 4
C COLITIS ULCERATIVE HAEMOGLOBIN DECREASED 4
C COLITIS ULCERATIVE HEPATIC NECROSIS 4
C COLITIS ULCERATIVE HEPATIC STEATOSIS 4
C COLITIS ULCERATIVE KLEBSIELLA TEST POSITIVE 4
C COLITIS ULCERATIVE MULTI-ORGAN FAILURE 4
C COLITIS ULCERATIVE PANCREATIC DISORDER 4
C COLITIS ULCERATIVE PLATELET COUNT DECREASED 4
C COLITIS ULCERATIVE PNEUMOCONIOSIS 4
C COLITIS ULCERATIVE PULMONARY EMBOLISM 4
C COLITIS ULCERATIVE RED BLOOD CELL COUNT DECREASED 4
C COLITIS ULCERATIVE RENAL FAILURE ACUTE 4
C COLITIS ULCERATIVE RESPIRATORY FAILURE 4
C COLITIS ULCERATIVE SEPSIS 4
C COLITIS ULCERATIVE SPLENIC INFARCTION 4
C COLITIS ULCERATIVE SPLENIC NECROSIS 4
C COLITIS ULCERATIVE WHITE BLOOD CELL COUNT DECREASED 4
Ads by Google